Complete Genomics

Complete Genomics is a life sciences company that has developed and commercialized an innovative DNA sequencing platform. The Complete Genomics Analysis Platform (CGA™ Platform) combines Complete Genomics’ proprietary human genome sequencing technology with our advanced informatics and data management software. We offer this solution as an innovative, end-to-end, outsourced service, CGA™ Service, and provide customers with data that is immediately ready to be used for genome-based research.


Current Investors/Backers

Complete Genomics, Inc. is backed by a group of top-tier investors including Essex Woodlands, Orbimed, OVP, Enterprise Partners, Prospect Ventures and Sands Capital Management.

For more information on Complete Genomics, Inc., please visit their web site at


ATEL Portfolio News